Leslie Sloan
2021
In 2021, Leslie Sloan earned a total compensation of $1.4M as Chief Operating Officer at Aeglea BioTherapeutics, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $200,000 |
|---|---|
| Salary | $410,000 |
| Stock Awards | $822,496 |
| Other | $16,940 |
| Total | $1,449,436 |
Sloan received $822.5K in stock awards, accounting for 57% of the total pay in 2021.
Sloan also received $200K in non-equity incentive plan, $410K in salary and $16.9K in other compensation.
Rankings
In 2021, Leslie Sloan's compensation ranked 7,396th out of 12,406 executives tracked by ExecPay. In other words, Sloan earned more than 40.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,396 out of 12,406 | 40th |
Division Manufacturing | 3,250 out of 5,494 | 41st |
Major group Chemicals And Allied Products | 1,438 out of 2,369 | 39th |
Industry group Drugs | 1,281 out of 2,090 | 39th |
Industry Pharmaceutical Preparations | 940 out of 1,537 | 39th |
Source: SEC filing on April 21, 2022.
Sloan's colleagues
We found two more compensation records of executives who worked with Leslie Sloan at Aeglea BioTherapeutics in 2021.